Eurofins Amatsi Analytics
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- France
- Registered address
- Parc De Genibrat, Fontenilles, 31470, France (FRA)
- Operations here
- analysis
- FDA identifiers
- FEI 3006118993 · DUNS 270324185
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBioresearch Monitoring2023-11-03
- VAIDrug Quality Assurance2021-08-05
- NAIDrug Quality Assurance2016-09-28
- NAIDrug Quality Assurance2014-02-04
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- Ferric MaltolShield TX (UK) Ltd
- SelexipagActelion Pharmaceuticals US, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.